Terms: = Ovarian cancer AND TRRAP, TR-AP, 8295, ENSG00000196367, Q9Y4A5, PAF400, PAF350/400, FLJ10671, STAF40, Tra1 AND Prognosis
59 results:
1. The IGF-PAPP-A-Stanniocalcin Axis in Serum and Ascites Associates with prognosis in Patients with ovarian cancer.
Hjortebjerg R; Høgdall C; Hansen KH; Høgdall E; Frystyk J
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396692
[TBL] [Abstract] [Full Text] [Related]
2. Microcystic, elongated and fragmented (MELF) pattern in endometrial carcinoma: clinicopathologic analysis and prognostic implications.
Song J; Li H; Guo H; Cai Y
Medicine (Baltimore); 2022 Oct; 101(43):e31369. PubMed ID: 36316927
[TBL] [Abstract] [Full Text] [Related]
3. Effect of BRCA1/2 Mutational Status on Survival Outcomes According to Secondary Cytoreductive Surgery and Maintenance Therapy in Platinum-Sensitive Relapsed ovarian cancer: A Real-World Evidence Study.
Kim SI; Lim H; Kim HS; Chung HH; Kim JW; Park NH; Song YS; Lee M
Cancer Res Treat; 2023 Jan; 55(1):245-257. PubMed ID: 35879854
[TBL] [Abstract] [Full Text] [Related]
4. Robust prognostic model based on immune infiltration-related genes and clinical information in ovarian cancer.
Zhang X; Kong W; Gao M; Huang W; Peng C; Huang Z; Xie Z; Guo H
J Cell Mol Med; 2022 Jul; 26(13):3659-3674. PubMed ID: 35735060
[TBL] [Abstract] [Full Text] [Related]
5. High expression level of miR-1260 family in the peripheral blood of patients with ovarian carcinoma.
Ghafour AA; Odemis DA; Tuncer SB; Kurt B; Saral MA; Erciyas SK; Erdogan OS; Celik B; Saip P; Yazici H
J Ovarian Res; 2021 Oct; 14(1):131. PubMed ID: 34629107
[TBL] [Abstract] [Full Text] [Related]
6. Multimodal Treatment of Primary Advanced ovarian cancer.
Friedrich M; Friedrich D; Kraft C; Rogmans C
Anticancer Res; 2021 Jul; 41(7):3253-3260. PubMed ID: 34230119
[TBL] [Abstract] [Full Text] [Related]
7. Nationwide population-based study of prevalence and trend of borderline ovarian tumors in the Republic of Korea.
Ouh YT; Kang D; Kim H; Lee JK; Hong JH
Sci Rep; 2021 May; 11(1):11158. PubMed ID: 34045639
[TBL] [Abstract] [Full Text] [Related]
8. Preoperative low hematocrit is an adverse prognostic biomarker in ovarian cancer.
Chen J; Li Y; Cui H
Arch Gynecol Obstet; 2021 Mar; 303(3):767-775. PubMed ID: 33011886
[TBL] [Abstract] [Full Text] [Related]
9. Paraneoplastic Dermatomyositis in a Patient with Metastatic Gastric Carcinoma.
Pozharashka J; Dourmishev L; Rusinova D; Balabanova M; Miteva L
Acta Dermatovenerol Croat; 2020 Aug; 28(2):120-122. PubMed ID: 32876041
[TBL] [Abstract] [Full Text] [Related]
10. Vegetable and Fruit Consumption and prognosis Among cancer Survivors: A Systematic Review and Meta-Analysis of Cohort Studies.
Hurtado-Barroso S; Trius-Soler M; Lamuela-Raventós RM; Zamora-Ros R
Adv Nutr; 2020 Nov; 11(6):1569-1582. PubMed ID: 32717747
[TBL] [Abstract] [Full Text] [Related]
11. A healthy lifestyle and survival among women with ovarian cancer.
Hansen JM; Nagle CM; Ibiebele TI; Grant PT; Obermair A; Friedlander ML; DeFazio A; Webb PM;
Int J Cancer; 2020 Dec; 147(12):3361-3369. PubMed ID: 32542708
[TBL] [Abstract] [Full Text] [Related]
12. Pazopanib and Oral Cyclophosphamide in Women With Platinum-Resistant or -Refractory Epithelial ovarian cancer.
Gulia S; Ghosh J; Bajpai J; Rath S; Maheshwari A; Shylasree TS; Deodhar K; Thakur M; Gupta S
JCO Glob Oncol; 2020 Mar; 6():542-547. PubMed ID: 32228315
[TBL] [Abstract] [Full Text] [Related]
13. Combined score of pretreatment platelet count and CA125 level (PLT-CA125) stratified prognosis in patients with FIGO stage IV epithelial ovarian cancer.
Chen JP; Huang QD; Wan T; Tu H; Gu HF; Cao JY; Liu JH
J Ovarian Res; 2019 Jul; 12(1):72. PubMed ID: 31362750
[TBL] [Abstract] [Full Text] [Related]
14. Fallopian Tube Lesions in Women at High Risk for ovarian cancer: A Multicenter Study.
Visvanathan K; Shaw P; May BJ; Bahadirli-Talbott A; Kaushiva A; Risch H; Narod S; Wang TL; Parkash V; Vang R; Levine DA; Soslow R; Kurman R; Shih IM
Cancer Prev Res (Phila); 2018 Nov; 11(11):697-706. PubMed ID: 30232083
[TBL] [Abstract] [Full Text] [Related]
15. Htra1 expression and the prognosis of high-grade serous ovarian carcinoma: a cohort study using digital analysis.
Gagné A; Têtu B; Orain M; Turcotte S; Plante M; Grégoire J; Renaud MC; Bairati I; Trudel D
Diagn Pathol; 2018 Aug; 13(1):57. PubMed ID: 30131069
[TBL] [Abstract] [Full Text] [Related]
16. A Temporal Examination of Platelet Counts as a Predictor of prognosis in Lung, Prostate, and Colon cancer Patients.
Sylman JL; Boyce HB; Mitrugno A; Tormoen GW; Thomas IC; Wagner TH; Lee JS; Leppert JT; McCarty OJT; Mallick P
Sci Rep; 2018 Apr; 8(1):6564. PubMed ID: 29700384
[TBL] [Abstract] [Full Text] [Related]
17. Novel ex vivo ovarian cancer tissue explant assay for prediction of chemosensitivity and response to novel therapeutics.
Ricciardelli C; Lokman NA; Sabit I; Gunasegaran K; Bonner WM; Pyragius CE; Macpherson AM; Oehler MK
Cancer Lett; 2018 May; 421():51-58. PubMed ID: 29425684
[TBL] [Abstract] [Full Text] [Related]
18. Preparation and characterization of a high-affinity monoclonal antibody against human epididymis protein-4.
Shen Y; Wang Y; Jiang X; Lu L; Wang C; Luo W; Zhang Y; Li P; Du Z; Dai T; Wu C; Fang A; Yao Y; Peng Q; Yang J
Protein Expr Purif; 2018 Jan; 141():44-51. PubMed ID: 28928083
[TBL] [Abstract] [Full Text] [Related]
19. Pazopanib (GW786034) and cyclophosphamide in patients with platinum-resistant, recurrent, pre-treated ovarian cancer - Results of the PACOVAR-trial.
Dinkic C; Eichbaum M; Schmidt M; Grischke EM; Gebauer G; Fricke HC; Lenz F; Wallwiener M; Marme F; Schneeweiss A; Sohn C; Rom J
Gynecol Oncol; 2017 Aug; 146(2):279-284. PubMed ID: 28528917
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in ovarian cancer: A Systematic Review and Meta-Analysis of Observational Studies.
Huang QT; Zhou L; Zeng WJ; Ma QQ; Wang W; Zhong M; Yu YH
Cell Physiol Biochem; 2017; 41(6):2411-2418. PubMed ID: 28467978
[TBL] [Abstract] [Full Text] [Related]
[Next]
